SI-BONE Inc
SIBN
62 hedge funds and large institutions have $298M invested in SI-BONE Inc in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 35 increasing their positions, 10 reducing their positions, and 9 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 10
32% more capital invested
Capital invested by funds: $225M → $298M (+$72.7M)
4% more ownership
Funds ownership: 51.41% → 55.41% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less funds holding
Funds holding: 66 → 62 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$7.46M |
| 2 |
Morgan Stanley
New York
|
-$4.22M |
| 3 |
Goldman Sachs
New York
|
-$3.97M |
| 4 |
BC
Broadfin Capital
New York
|
-$3.95M |
| 5 |
AR
Advisory Research
Chicago,
Illinois
|
-$681K |
SIBN Hedge Fund Activity: Q4 2019 in Review
62 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in SI-BONE Inc (SIBN) for Q4 2019, worth a combined $298M — up 32% from $225M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SIBN and 5 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 35 added.
The largest buyer was Millennium Management, adding an estimated $9.53M. The largest seller was OrbiMed, exiting entirely with an estimated $7.46M sold.
- 62 institutional investors held SI-BONE Inc (SIBN) as of Q4 2019, down from 66 in Q3 2019.
- Funds reported $298M of SI-BONE Inc stock for Q4 2019, up 32% quarter-over-quarter.
- 5 funds opened new SI-BONE Inc positions in Q4 2019 and 9 closed out, a net change of -4 holders.
- The largest SI-BONE Inc buyer in Q4 2019 was Millennium Management, an estimated $9.53M added.
- The largest SI-BONE Inc seller in Q4 2019 was OrbiMed, an estimated $7.46M sold.
Based on aggregated 13F filings for Q4 2019.